We are thrilled to share that we will be exhibiting in Lyon next week at the JIVD/ERCA conference 2022, from March 3rd to 5th. The team is so glad and can’t wait to reconnect face-to-face with the pulmonary international medical community! We will showcase our #simeox device and associated support programs, as well as providing the latest updates on the clinical front! Very much looking forward to!
🌿 Laurent Morin Medical Affairs Director at PhysioAssist, will be one of the speakers during the symposium organized by ‘GROUPE AGIR à dom’ as part of the JIVD/ERCA 2022 conference, on Thursday, March 3 from 5:30 to 7 pm. This symposium, entitled “What lessons can be drawn from the Covid-19 pandemic for the follow-up of patients with chronic respiratory failure at home – the place of telehealth?” will be chaired by jean Louis Pepin and Borel Jean-Christian.
Laurent will be presenting the preliminary results of the Homecare Bronchiectasis trial (NCT04742270). The aim of this trial was to assess the feasibility of implementing Simeox therapy at home using telecare in non-CF-Bronchiectasis patients, as well as evaluating the adherence to the Simeox therapy and other criteria (among which quality of life, patient satisfaction, etc.) over a follow-up period of 3 months.
🌿 Thank you ‘GROUPE AGIR à dom’ for this opportunity to present the results of this innovative-designed trial, based on the Simeox remote setup experience we have developed and consolidated during the Covid-19 pandemic. Looking forward to unveiling those results! Don’t miss the symposium! The results of the Homecare Bronchiectasis trial will also be presented (oral communication) on Friday, March 4 at 10 am, in-room Forum 1.